Navigation Links
Jefferson scientists find high glucose before surgery raises risk of dangerous complications

Patients who have high blood sugar before undergoing surgery run an increased risk of developing blood clots, deep vein thrombosis and even pulmonary embolism after surgery.

Boris Mraovic, M.D., assistant professor of anesthesiology in the Artificial Pancreas Center at Jefferson Medical College of Thomas Jefferson University in Philadelphia, and his colleagues examined records of nearly 6,500 hip or knee replacement surgery patients at Thomas Jefferson University Hospital who were admitted between 2003 and 2005. They asked what happened to patients with high blood sugar that wasn't well controlled prior to surgery.

Of these patients, 38 had very high blood glucose ?more than 250 mg/dl ?on the day of preoperative testing and the day of surgery. The team found that approximately 10.5 percent of the patients with high blood sugar developed a pulmonary embolism, a life-threatening condition in which blood clots travel to the lungs, after surgery, a rate that is 6.2 times greater than would be expected in the general population. The researchers report their results on October 15, 2006 at the annual meeting of the American Society of Anesthesiologists in Chicago.

"These data suggest that if an individual has high blood glucose and is coming for surgery, he or she should correct it first and probably postpone the surgery," says Dr. Mraovic.

Physicians should also be aware of these risks, he notes, and should make it a priority to be sure that patient glucose levels are under control prior to and during surgery.

Dr. Mraovic says that as many as 25 percent of all surgery patients come to the hospital with high blood sugar. Another 10 percent have raised levels due to pre-surgery stress. Deep vein thrombosis occurs in approximately two million Americans each year. Pulmonary embolism (PE), which can cause sudden death, occurs when a clot dislodges from the vein and circulates into the lungs. Each year some 600,000 patients develop PE
'"/>

Source:Thomas Jefferson University


Page: 1 2

Related biology news :

1. Jefferson Virologists Coax HIV Out of Hiding
2. Jefferson researchers find nanoparticle shows promise in reducing radiation side effects
3. Jefferson biologist coaxing human embryonic stem cells to make dopamine with simpler, faster method
4. Jefferson scientists identify gene defect leading to abnormal skin development and cancer
5. Jefferson researchers building a better rabies vaccine
6. Jefferson scientists identify gene mutation potentially involved in breast cancer initiation
7. Immune cell communication key to hunting viruses, Jefferson immunologists show
8. Jefferson researchers uncover new way nature turns genes on and off
9. Jefferson scientists find aging gene also protects against prostate cancer development
10. Jefferson researchers discovery may change thinking on how viruses invade the brain
11. Elderly spinal cord injuries increase five-fold in 30 years, Jefferson neurosurgeons find

Post Your Comments:
(Date:11/4/2009)...lencoe Software, Inc., the commercial arm of the O...p://openmicroscopy.org ), is proud to announce it...Biology,s exciting new project titled "The Cell: A...M stimulus grant through the National Institutes o...art of the American Reinvestment and Recovery Act,...
(Date:11/3/2009)... published in a recent issue of HortTechnology , ... the effects of covering orchard floors with refle...light distribution, orchard temperature, and profi...enday and Solarmate films installed 5 weeks before...apples. The research showed that the use of both f...
(Date:11/3/2009)...li School of Engineering and Applied Science have ...he laboratory the enzyme responsible for producing...tin. , The research, published Oct. 23 in the...development of other compounds with similarly bene... enzyme is one of the most interesting but least u...
Breaking Biology News(10 mins):Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Reflective film can boost profits for apple growers 2UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 2Predictors of disease behavior change in Crohn 26 23146 3Bs disease 54046 1Potato blight plight looks promising for food security 9526 1Potato blight plight looks promising for food security 9526 2Fertility Can Be Preserved in Ovarian Cancer Patients 54043 1Fertility Can Be Preserved in Ovarian Cancer Patients 54043 2
...Researchers have created an algorithm that meshes ...ow chart of how cells respond to stimuli. Using th...ts Institute of Technology scientists have analyze...athways that can affect cell survival. Misfolded c...s are a hallmark of Parkinson,s disease. , RELEVA...
...2, 2009--Researchers at the Dana-Farber Cancer Ins...l Research (Burnham) and the Centers for Disease C...tification of human monoclonal antibodies (mAb) th...A viruses, including avian influenza A (H5N1) viru...easonal influenza viruses. These antibodies have t...
...ss., Feb. 17 LocatePLUS Holdings Corporation (Pin...ss-to-government provider of investigative, identi...ounced today the January 26, 2009 election of an e... election of a reconstituted independent Board thr...pletes a transition initiated by stockholders over...
Other Biology News:Calculating gene and protein connections in a Parkinson's disease model 2Calculating gene and protein connections in a Parkinson's disease model 3Calculating gene and protein connections in a Parkinson's disease model 4Scientists identify human monoclonal antibodies effective against bird and seasonal flu viruses 2Scientists identify human monoclonal antibodies effective against bird and seasonal flu viruses 3LocatePLUS Announces Election of Independent Board 2LocatePLUS Announces Election of Independent Board 3LocatePLUS Announces Election of Independent Board 4
(Date:11/5/2009).../ -- Imagenetix, Inc. (OTC Bulletin Board: IAGX), ...d CEO of Imagenetix, will be presenting the Compan... Thursday, December 3rd, at 10:30 AM PST at the Lu..., LD MICRO is a by-invitation only newsletter fir... the micro-cap space. Since 2002, the firm has pub...
(Date:11/5/2009)...ll/ -- Transgenomic, Inc. (OTC Bulletin Board: TBI...er ended September 30, 2009. The Company,s financi.... ,, Third Quarter 2009 ,, The Company rep...r the third quarter of 2009 as compared to a net l...uarter of 2008. ,, Net sales were $5.0 million...
(Date:11/5/2009)...irstCall/ -- Wound Management Technologies, Inc., ... Letter of Intent to purchase all healthcare-relat...C Bulletin Board: VHGI). The deal provides for VHG...0 shares of WNDM and a royalty agreement for reven...being acquired from VHGI. WNDM closed at $2.00 p...
(Date:11/5/2009)...pineSmith Partners has signed an initial agreement...ld that mimics the structure of natural cancellous... products by SpineSmith,s Research and Development...ffold represents a significant advancement in tech... for the delivery of adult stem cells for skeletal...
Breaking Biology Technology:Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
...AVIV, Israel, October 15 ,Simbionix USA Corporatio...s,C round of growth capital financing led by River...r Early Stage Partners and other existing,sharehol...ed as the,company,s investment bankers. The invest...dy rapid growth of its medical simulation technolo...
...Cryo-Cell,International, Inc. (OTC Bulletin Board:... and most established family cord blood banks, tod...e months ended August 31,2008., Consolidated reve...,million compared to approximately $4.6 million fo...a net loss in the third quarter 2008 of,approximat...
...dership Position in Targeting Chemokine Receptor ...s, MOUNTAIN VIEW, Calif., Oct. 15 ChemoCentryx, ... I clinical trial of CCX025,the company,s fourth i...ered compound that inhibits the chemokine receptor...t-EN(TM) (CCX282-B; ChemoCentryx,s CCR9,antagonist...
Other Biology Technology:Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth 2Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth 3Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 2Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 3Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 4Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 5Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 6ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development 2ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development 3ChemoCentryx Advances Second Orally Available CCR9 Antagonist CCX025 Into Clinical Development 4
Collar for Vac-Man® 96 Vacuum Manifold from Promega
IPTG Solution from Bioline
MagneSil KF, Genomic System from Promega
Lipofectin Reagent from Invitrogen
Biology Products: